(E)-2-CYANO-3-(4,5-DIMETHOXY-2-NITROPHENYL)ACRYLAMIDE, 95.0%, 500mg

Eicosanedioic Acid>98.0%(T)25g

(S)-5-Methoxy-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride, 95%, 100g

3-Bromo-5-fluoro-N,N-dimethylaniline, 97%, 5g

5-(4-Fluorophenyl)-2H-pyrazol-3-ylamine, 95.0%, 250mg

(E)-3-(Dimethylamino)acrylonitrile, 95.0%, 100g

Indican, 99.41%, 25mg

(4R)-4-[(1S)-1-fluoroethyl]-3-(2-{[(1S)-1-[4-methyl-2'-(trifluoromethyl)-[3,4'-bipyridin]-6-yl]ethyl]amino}pyrimidin-4-yl)-1,3-oxazolidin-2-one, 1mg

5-(2-Methylbut-3-yn-2-yl)-1,3,4-thiadiazol-2-amine, 95%, 100mg

(2-Methyl-5-(morpholinosulfonyl)phenyl)boronic acid, 95.0%, 5g

Theobromine>98.0%(HPLC)(T)500g

Berbamine dihydrochloride, 96.62%, 250mg

Plan stress-free PLPOLi 20x/0.40 IOS objective for iScope incident polarization, no cover glass correction. Working distance 5.8 mm